These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26908796)

  • 1. A Phase 3, Double-Blind, Randomized Study of Arterolane Maleate-Piperaquine Phosphate vs Artemether-Lumefantrine for Falciparum Malaria in Adolescent and Adult Patients in Asia and Africa.
    Toure OA; Valecha N; Tshefu AK; Thompson R; Krudsood S; Gaye O; Rao BHK; Sagara I; Bose TK; Mohanty S; Rao BS; Anvikar AR; Mwapasa V; Noedl H; Arora S; Roy A; Iyer SS; Sharma P; Saha N; Jalali RK; ; Tiacoh L; Enosse S; Tangpukdee N; Kokolomami J; Ndiaye JL; Rao D; Yumva NN; Sidibe B; Mohanty R; Jha AC; Nyirenda M; Starzengruber P; Swoboda P
    Clin Infect Dis; 2016 Apr; 62(8):964-971. PubMed ID: 26908796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Efficacy and Safety of Arterolane Maleate-Piperaquine Phosphate Dispersible Tablets in Comparison With Artemether-Lumefantrine Dispersible Tablets in Pediatric Patients With Acute Uncomplicated Plasmodium falciparum Malaria: A Phase 3, Randomized, Multicenter Trial in India and Africa.
    Toure OA; Mwapasa V; Sagara I; Gaye O; Thompson R; Maheshwar AV; Mishra P; Behra N; Tshefu AK; Das RR; Anvikar AR; Sharma P; Roy A; Sharma SK; Nasa A; Jalali RK; Valecha N;
    Clin Infect Dis; 2017 Oct; 65(10):1711-1720. PubMed ID: 29020247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of fixed dose combination of arterolane maleate and piperaquine phosphate dispersible tablets in paediatric patients with acute uncomplicated Plasmodium falciparum malaria: a phase II, multicentric, open-label study.
    Toure OA; Rulisa S; Anvikar AR; Rao BS; Mishra P; Jalali RK; Arora S; Roy A; Saha N; Iyer SS; Sharma P; Valecha N
    Malar J; 2015 Nov; 14():469. PubMed ID: 26608469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial.
    Hamaluba M; van der Pluijm RW; Weya J; Njuguna P; Ngama M; Kalume P; Mwambingu G; Ngetsa C; Wambua J; Boga M; Mturi N; Lal AA; Khuroo A; Taylor WRJ; Gonçalves S; Miotto O; Dhorda M; Mutinda B; Mukaka M; Waithira N; Hoglund RM; Imwong M; Tarning J; Day NPJ; White NJ; Bejon P; Dondorp AM
    Lancet Infect Dis; 2021 Oct; 21(10):1395-1406. PubMed ID: 34111412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterolane maleate plus piperaquine phosphate for treatment of uncomplicated Plasmodium falciparum malaria: a comparative, multicenter, randomized clinical trial.
    Valecha N; Krudsood S; Tangpukdee N; Mohanty S; Sharma SK; Tyagi PK; Anvikar A; Mohanty R; Rao BS; Jha AC; Shahi B; Singh JP; Roy A; Kaur P; Kothari M; Mehta S; Gautam A; Paliwal JK; Arora S; Saha N
    Clin Infect Dis; 2012 Sep; 55(5):663-71. PubMed ID: 22586253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the safety and efficacy of fixed-dose combination of arterolane maleate and piperaquine phosphate with chloroquine in acute, uncomplicated Plasmodium vivax malaria: a phase III, multicentric, open-label study.
    Valecha N; Savargaonkar D; Srivastava B; Rao BH; Tripathi SK; Gogtay N; Kochar SK; Kumar NB; Rajadhyaksha GC; Lakhani JD; Solanki BB; Jalali RK; Arora S; Roy A; Saha N; Iyer SS; Sharma P; Anvikar AR
    Malar J; 2016 Jan; 15():42. PubMed ID: 26818020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.
    Tshefu AK; Gaye O; Kayentao K; Thompson R; Bhatt KM; Sesay SS; Bustos DG; Tjitra E; Bedu-Addo G; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L;
    Lancet; 2010 Apr; 375(9724):1457-67. PubMed ID: 20417857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children.
    Nambozi M; Van Geertruyden JP; Hachizovu S; Chaponda M; Mukwamataba D; Mulenga M; Ubben D; D'Alessandro U
    Malar J; 2011 Feb; 10():50. PubMed ID: 21352609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of arterolane maleate following multiple oral doses in adult patients with P. falciparum malaria.
    Gautam A; Ahmed T; Sharma P; Varshney B; Kothari M; Saha N; Roy A; Moehrle JJ; Paliwal J
    J Clin Pharmacol; 2011 Nov; 51(11):1519-28. PubMed ID: 21148048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial.
    Sirima SB; Ogutu B; Lusingu JPA; Mtoro A; Mrango Z; Ouedraogo A; Yaro JB; Onyango KO; Gesase S; Mnkande E; Ngocho JS; Ackermann I; Aubin F; Vanraes J; Strub N; Carn G
    Lancet Infect Dis; 2016 Oct; 16(10):1123-1133. PubMed ID: 27430374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa.
    Yavo W; Faye B; Kuete T; Djohan V; Oga SA; Kassi RR; Diatta M; Ama MV; Tine R; Ndiaye JL; Evi JB; Same-Ekobo A; Faye O; Koné M
    Malar J; 2011 Jul; 10():198. PubMed ID: 21774826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of efficacy and safety of artesunate-lumefantrine vs. artemether-lumefantrine fixed-dose combination in the treatment of uncomplicated Plasmodium falciparum malaria.
    Pareek A; Chandurkar N; Srivastav V; Lakhani J; Karmakar PS; Basu S; Ray A; Pednekar S; Gupta PB; Suthar N; Lakhani S
    Trop Med Int Health; 2013 May; 18(5):578-87. PubMed ID: 23489465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria.
    Premji Z; Umeh RE; Owusu-Agyei S; Esamai F; Ezedinachi EU; Oguche S; Borrmann S; Sowunmi A; Duparc S; Kirby PL; Pamba A; Kellam L; Guiguemdé R; Greenwood B; Ward SA; Winstanley PA
    PLoS One; 2009 Aug; 4(8):e6682. PubMed ID: 19690618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterolane, a new synthetic trioxolane for treatment of uncomplicated Plasmodium falciparum malaria: a phase II, multicenter, randomized, dose-finding clinical trial.
    Valecha N; Looareesuwan S; Martensson A; Abdulla SM; Krudsood S; Tangpukdee N; Mohanty S; Mishra SK; Tyagi PK; Sharma SK; Moehrle J; Gautam A; Roy A; Paliwal JK; Kothari M; Saha N; Dash AP; Björkman A
    Clin Infect Dis; 2010 Sep; 51(6):684-91. PubMed ID: 20687837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria.
    Macintyre F; Adoke Y; Tiono AB; Duong TT; Mombo-Ngoma G; Bouyou-Akotet M; Tinto H; Bassat Q; Issifou S; Adamy M; Demarest H; Duparc S; Leroy D; Laurijssens BE; Biguenet S; Kibuuka A; Tshefu AK; Smith M; Foster C; Leipoldt I; Kremsner PG; Phuc BQ; Ouedraogo A; Ramharter M;
    BMC Med; 2017 Oct; 15(1):181. PubMed ID: 28988541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.
    Mwaiswelo R; Ngasala B; Jovel I; Aydin-Schmidt B; Gosling R; Premji Z; Mmbando B; Björkman A; Mårtensson A
    Malar J; 2016 Aug; 15(1):435. PubMed ID: 27565897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda.
    Yeka A; Dorsey G; Kamya MR; Talisuna A; Lugemwa M; Rwakimari JB; Staedke SG; Rosenthal PJ; Wabwire-Mangen F; Bukirwa H
    PLoS One; 2008 Jun; 3(6):e2390. PubMed ID: 18545692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of fixed dose combination of arterolane maleate and piperaquine phosphate in comparison with chloroquine phosphate in children with acute uncomplicated
    Valecha N; Goyal VK; Mishra DN; Das RR; Jauhri N; Bhardwaj AC; Khurana O; Choudhury R; Pandey M; Baliga BS; Ghosh SK; Srivastava B; Soans ST; Bahl RK; Punj A; Roy A; Sharma SK; Nasa A; Jalali RK; Anvikar AR
    J Vector Borne Dis; 2020; 57(3):213-220. PubMed ID: 34472504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of the efficacy and tolerability of dihydroartemisinin-piperaquine-trimethoprim versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroon, Ivory Coast and Senegal.
    Menan H; Faye O; Same-Ekobo A; Oga AS; Faye B; Kiki Barro CP; Kuete T; N'diaye JL; Vicky AM; Tine R; Yavo W; Kane D; Kassi KF; Kone M
    Malar J; 2011 Jul; 10():185. PubMed ID: 21740570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.